Lapatinib-13C2,15N

Lapatinib-13C2,15N Struktur
CAS-Nr.
Englisch Name:
Lapatinib-13C2,15N
Synonyma:
Tykerb-13C2,15N;GW 572016-13C2,15N;Lapatinib-13C2,15N;GW 572016X-13C2,15N;GW-572016F-13C2,15N;GSK 572016-13C2,15N;Tykerb-13C2,15N Ditosylate;N-[3-Chloro-4-[(3-fluorophenyl)Methoxy]phenyl]-6-[5-[[[2-(Methylsulfonyl)ethyl]aMino]Methyl]-2-furanyl]-4-quinazolinaMine-13C2,15N;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine Bis(4-methylbenzenesulfonate)-13C2,15N;N-[3-Chloro-4-[(3-fluorophenyl)Methoxy]phenyl]-6-[5-[[[2-(Methylsulfonyl)ethyl]aMino]Methyl]-2-furanyl]-4-quinazolinaMine Bis(4-Methylbenzenesulfonate)-13C2,15N Ditosylate
CBNumber:
CB01565003
Summenformel:
C2713C2H26ClFN315NO4S
Molgewicht:
0
MOL-Datei:
Mol file

Lapatinib-13C2,15N Eigenschaften

Schmelzpunkt:
240-2420C
storage temp. 
-20°C Freezer
Löslichkeit
DMSO (Slightly), Methanol (Very Slightly)
Aggregatzustand
Solid
Farbe
Pale Yellow to Yellow

Sicherheit

Lapatinib-13C2,15N Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Yellow Solid

Verwenden

Labelled Lapatinib (L175800). Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic.

Lapatinib-13C2,15N Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Lapatinib-13C2,15N Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chemsky(shanghai)International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50

  • GW-572016F-13C2,15N
  • Lapatinib-13C2,15N
  • N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine Bis(4-methylbenzenesulfonate)-13C2,15N
  • Tykerb-13C2,15N
  • N-[3-Chloro-4-[(3-fluorophenyl)Methoxy]phenyl]-6-[5-[[[2-(Methylsulfonyl)ethyl]aMino]Methyl]-2-furanyl]-4-quinazolinaMine Bis(4-Methylbenzenesulfonate)-13C2,15N Ditosylate
  • Tykerb-13C2,15N Ditosylate
  • GSK 572016-13C2,15N
  • GW 572016-13C2,15N
  • GW 572016X-13C2,15N
  • N-[3-Chloro-4-[(3-fluorophenyl)Methoxy]phenyl]-6-[5-[[[2-(Methylsulfonyl)ethyl]aMino]Methyl]-2-furanyl]-4-quinazolinaMine-13C2,15N
  • C2713C2H26ClFN315NO4S
  • Intermediates & Fine Chemicals
  • Isotope Labeled Compounds
  • Pharmaceuticals
  • Tyrosine Kinase Inhibitors
  • Isotope Labelled Compounds
Copyright 2019 © ChemicalBook. All rights reserved